Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheeba K Thomas

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|November 29, 2024
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplantCurtis Marcoux, Sarah Pasyar, Denái R Milton, et al.
Transplantation and Cellular Therapy|December 20, 2025
Post-Transplant Outcomes in IgD Multiple Myeloma: A Propensity Score-Matched AnalysisCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2016
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell TransplantationFabian Bock, Gary Lu, Samer A Srour, et al.
Transplantation and Cellular Therapy|March 25, 2022
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Oren Pasvolsky, Junsheng Ma, et al.
Blood Cancer Journal|January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experienceOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Transplantation and Cellular Therapy|June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three DecadesOren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Transplantation and Cellular Therapy|May 18, 2025
Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous TransplantationOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Transplantation and Cellular Therapy|August 2, 2025
Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell TransplantCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Leukemia & Lymphoma|June 26, 2026
D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparisonOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|November 29, 2024
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplantCurtis Marcoux, Sarah Pasyar, Denái R Milton, et al.
Transplantation and Cellular Therapy|December 20, 2025
Post-Transplant Outcomes in IgD Multiple Myeloma: A Propensity Score-Matched AnalysisCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2016
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell TransplantationFabian Bock, Gary Lu, Samer A Srour, et al.
Transplantation and Cellular Therapy|March 25, 2022
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Oren Pasvolsky, Junsheng Ma, et al.
Blood Cancer Journal|January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experienceOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Transplantation and Cellular Therapy|June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three DecadesOren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Transplantation and Cellular Therapy|May 18, 2025
Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous TransplantationOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Transplantation and Cellular Therapy|August 2, 2025
Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell TransplantCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Leukemia & Lymphoma|June 26, 2026
D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparisonOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Pageof 12